The launch of anti-obesity drug orlistat as a pharmacy medicine this week is a step in the right direction for patients needing effective weight-management care and expert advice, the Royal Pharmaceutical Society of Great Britain (RPSGB) said today.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.